BiotechTube
Home/AnHorn Medicines/Dr. Lin Chu‑Chiang
DL

Dr. Lin Chu‑Chiang

Founder & CEO

AnHorn Medicines

Therapeutic Areas

OncologyNeurodegenerationAging

AnHorn Medicines Pipeline

DrugIndicationPhase
AH-001Undisclosed (likely oncology or neurodegeneration)Phase 1